Larimar Therapeutics
LRMR
LRMR
71 hedge funds and large institutions have $31.5M invested in Larimar Therapeutics in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 26 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
46% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 24
60% less capital invested
Capital invested by funds: $78.5M → $31.5M (-$47M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $13K
Holders
71
Holding in Top 10
2
Calls
–
Puts
$13K
Top Buyers
| 1 | +$830K | |
| 2 | +$699K | |
| 3 | +$675K | |
| 4 |
Goldman Sachs
New York
|
+$575K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$316K |
Top Sellers
| 1 | -$1.92M | |
| 2 | -$1.67M | |
| 3 | -$1.48M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.07M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$800K |